Ads
related to: bristol-myers squibb stock price today
Search results
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 6 hours agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
10 Health Care Stocks With Whale Alerts In Today's Session - Charles River (NYSE:CRL), Bristol-Myers...
Benzinga· 6 days agoThis particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $39.1K , with a price of $193.0 ...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 2 days agoAt its recent market price of $44.74 per share, that means the company is available for around 6.5...
Getting In on This “Macro-Trend”
InvestorPlace· 5 days agoThe biotech sector, in particular, is offering a compelling and timely opportunity. In fact, I made this recommendation to my Fry’s Investment Report...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks via Yahoo Finance· 4 days agoNet loss for 2024 is expected in the band of $229-$255 million. PRTA currently carries a Zacks Rank...
Bull of the Day: Veeva Systems (VEEV)
Zacks via Yahoo Finance· 13 hours agoThe tech firm and the stock are proven winners. Now might be the time for investors to heed tried-and-true investment advice and buy Veeva while others...
North American Morning Briefing: Stock Futures Rise With Inflation Data In Focus This Week
Morningstar· 11 hours agoStock futures were modestly higher on Monday ahead of a key inflation reading later in the week which investors will scrutinize as expectations have shifted over when and ...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 4 days agoHighly Rated Biotech Stock Today, Neurocrine stock has a strong Composite Rating of 97 out of a...
Earnings call: Editas Medicine outlines strategic pillars for 2024
Investing.com· 5 days agoEditas Medicine (NASDAQ: EDIT ) has reported significant strides in its first quarter of 2024,...
Earnings call: 2seventy bio eyes growth with focus on Abecma in Q1 2024 By Investing.com
Investing.com· 4 days ago2seventy bio (Ticker: TSVB) reported its financial results and business updates during its First...
